Giuseppina Miele

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Monoclonal Antibody

Disease Activity

Rheumatoid Arthritis Patients

Top Venues

Journal of clinical medicine

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

This page only lists publications with an associated author ORCID identifier.

Publications

Floriana Bile, Maddalena Sparaco, Eleonora Ruocco, Giuseppina Miele, Elisabetta Maida, Renato Vele, Davide Mele, Simona Bonavita, Luigi Lavorgna
Dermatological Neoplastic Diseases Complicating Treatment with Monoclonal Antibodies for Multiple Sclerosis. Journal of clinical medicine 13 (17) (2024)
Giuseppina Miele, Simone Cepparulo, Gianmarco Abbadessa, Luigi Lavorgna, Maddalena Sparaco, Vittorio Simeon, Lorenzo Guizzaro, Simona Bonavita
Clinically Manifest Infections Do Not Increase the Relapse Risk in People with Multiple Sclerosis Treated with Disease-Modifying Therapies: A Prospective Study. Journal of clinical medicine 12 (3) (2023)
Elisabetta Signoriello, Giacomo Lus, Francesco Saccà, Marco Puthenparampil, Cinzia Coppola, Andrea Di Pietro, Gianfranco Puoti, Maria Cristina Criscuolo, Matteo Foschi, Giuseppina Miele, Gianmarco Abbadessa, Vincenzo Brescia Morra, Paolo Gallo, Simona Bonavita, Maria Pia Sormani, Alessio Signori
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence. Journal of clinical medicine 12 (5) (2023)
Giuseppina Miele, Simone Cepparulo, Gianmarco Abbadessa, Luigi Lavorgna, Maddalena Sparaco, Vittorio Simeon, Lorenzo Guizzaro, Simona Bonavita
Clinically Manifest Infections Do Not Increase the Relapse Risk in People with Multiple Sclerosis Treated with Disease-Modifying Therapies: A Prospective Study. Journal of clinical medicine 12 (3) (2023)
Giuseppina Miele, Gianmarco Abbadessa, Elisabetta Maida, Simona Bonavita
Viral pericarditis following ocrelizumab in a multiple sclerosis patient. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2023)
Giuseppina Miele, Roberta Lanzillo, Luigi Lavorgna
Can the use of telemedicine facilitate online prescribing for multiple sclerosis treatment? Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2023)
Elisabetta Signoriello, Giacomo Lus, Francesco Saccà, Marco Puthenparampil, Cinzia Coppola, Andrea Di Pietro, Gianfranco Puoti, Maria Cristina Criscuolo, Matteo Foschi, Giuseppina Miele, Gianmarco Abbadessa, Vincenzo Brescia Morra, Paolo Gallo, Simona Bonavita, Maria Pia Sormani, Alessio Signori
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence. Journal of clinical medicine 12 (5) (2023)
Giuseppina Miele, Gianmarco Abbadessa, Elisabetta Maida, Simona Bonavita
Viral pericarditis following ocrelizumab in a multiple sclerosis patient. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2023)
Giuseppina Miele, Gianmarco Abbadessa, Elisabetta Maida, Simona Bonavita
Viral pericarditis following ocrelizumab in a multiple sclerosis patient. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2023)
Giuseppina Miele, Simone Cepparulo, Gianmarco Abbadessa, Luigi Lavorgna, Maddalena Sparaco, Vittorio Simeon, Lorenzo Guizzaro, Simona Bonavita
Clinically Manifest Infections Do Not Increase the Relapse Risk in People with Multiple Sclerosis Treated with Disease-Modifying Therapies: A Prospective Study. Journal of clinical medicine 12 (3) (2023)